August 9, 2016 / 10:02 PM / a year ago

BRIEF-Valeant updates on settlement agreements related to Salix unit

1 Min Read

Aug 9 (Reuters) - Valeant Pharmaceuticals

* Estimated legal liability, initially measured at fair value on date of Salix acquisition, should be reduced by $39 million

* Co and the states have executed settlement agreements concerning the states' portion of the settlement related to Salix

* Pursuant to terms of agreements, co will make a payment of about $8 million plus interest by august 18, 2016

* Following execution of settlement concerning federal claims against Salix, co concluded its estimated legal liability relating to this matter

* Adjustment was recorded in other income in Q2 of 2016 in the co's consolidated statement of loss Source text: bit.ly/2aQ7jYe Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below